AstraZeneca fined $110 million for corrupt marketing scheme targeting children and vulnerable patients
In yet another stunning revelation of the pharmaceutical industry's corrupt stranglehold on American healthcare, AstraZeneca has been forced to pay $110 million to settle two whistleblower lawsuits brought by the state of Texas. The settlements, announced in 2014, expose a calculated scheme by the British-Swedish drug giant to defraud the…
Read More...
Read More...